ACE Technology Guidances

ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 01 Apr 2020
Last Updated on 01 Apr 2020
A- A+
Guidance Recommendations
The Ministry of Health’s Drug Advisory Committee has recommended:
  • Omeprazole 40 mg injection; and
  • Pantoprazole 40 mg injection

in line with their registered indications in Singapore for gastric anti-secretory treatment when oral therapies are unsuitable.

Subsidy status
Omeprazole 40 mg injection and pantoprazole 40 mg injection are recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.

SDL subsidy does not apply to esomeprazole 40 mg injection.

IV PPIs for gastric anti-secretory treatment (1 Apr 2020) IV PPIs for gastric anti-secretory treatment PES (1 Apr 2020)